Cargando…
A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 1.4 million deaths worldwide. Repurposing existing drugs offers the fastest opportunity to identify new indications for existing drugs as a stable solution against coronavirus disease 2019 (COVID-19). The SARS-CoV-2 mai...
Autores principales: | Kumar, Raj, Kumar, Vikas, Lee, Keun Woo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748973/ https://www.ncbi.nlm.nih.gov/pubmed/33360831 http://dx.doi.org/10.1016/j.compbiomed.2020.104186 |
Ejemplares similares
-
Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers
por: Labay, Edwardine, et al.
Publicado: (2016) -
Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020) -
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
por: Peele, K.Abraham, et al.
Publicado: (2021) -
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
por: Borcherding, Nicholas, et al.
Publicado: (2020) -
Repurposing clinically approved cephalosporins for tuberculosis therapy
por: Ramón-García, Santiago, et al.
Publicado: (2016)